TP53 and neoplasm: Here we have investigated the outcomes of AURKBi treatment in RB+p53 defective tumour cell lines to determine whether the polyploid cells can undergo reductive cell divisions to produce viable daughter cells, and whether they have long-term proliferative potential as reported for PGCCs.